Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965–2007

References

• Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 2009;136:1134–44.
   PubMed Web of Science ®Google Scholar
• Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W. Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003). Cancer Causes Control 2008;19:89–96.
   PubMed Web of Science ®Google Scholar
• Katanoda K, Dongmei Q. Comparison of time trends in pancreatic cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J Clin Oncol 2008;38:165–6.
   PubMedGoogle Scholar
• Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008;10:58–62.
   PubMed Web of Science ®Google Scholar
• Zhang J, Dhakal I, Yan H, Phillips M, Kesteloot H. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002. Ann Oncol 2007;18:1268–79.
   PubMed Web of Science ®Google Scholar
• Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000. Acta Oncol 2007;46:1064–9.
   PubMed Web of Science ®Google Scholar
• Fitzsimmons D, Osmond C, George S, Johnson CD. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000. Br J Surg 2007;94:1162–71.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Pisani P, Parkin DM GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press; 2004.
   Google Scholar
• Tumours of the exocrine pancreas. In: Hamilton SR, Aaltonen LA, editors. Pathology and Genetics. Tumours of the Digestive System (WHO Classification of Tumours, Volume 2, Third Edition). Lyon, France: IARC Press; 2000. p. 220–51.
   Google Scholar
• Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006;24:87–94.
   PubMed Web of Science ®Google Scholar
• Hruban RH, Maitra A, Goggins M. Update on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol 2008;1:306–16.
   PubMed Web of Science ®Google Scholar
• Buchler MW, Kleeff J, Friess H. Surgical treatment of pancreatic cancer. J Am Coll Surg 2007;205(4 Suppl):S81–6.
   Google Scholar
• Ko AH, Tempero MA. Personalized medicine for pancreatic cancer: a step in the right direction. Gastroenterology 2009;136:43–5.
   PubMedGoogle Scholar
• Sharp L, Carsin AE, Cronin-Fenton DP, O’Driscoll D, Comber H. Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland. Eur J Cancer 2009 May;45(8):1450–9.
   Google Scholar
• Brenner H, Hakulinen T. Maximizing the benefits of model-based period analysis of cancer patient survival. Cancer Epidemiol Biomarkers Prev 2007;16:1675–81.
   PubMedGoogle Scholar
• Estève J, Benhamou E, Raymond L Descriptive epidemiology. In: Statistical methods in cancer research, Vol. IV. IARC Science Publications; Lyon, France. 1994. p. 128.
   Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38:933–42.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–10.
   PubMed Web of Science ®Google Scholar
• Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002;360:1131–5.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826–32.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Coviello E, Hills M. Estimating and modelling relative survival. Stata J 2009; In press.
   Google Scholar
• Teiblum S, Thygesen LC, Johansen C. Sixty-one years of pancreatic cancer in Denmark from 1943 to 2003: a nationwide study. Pancreas 2009;38:374–8.
   PubMed Web of Science ®Google Scholar
• Wood HE, Gupta S, Kang JY, Quinn MJ, Maxwell JD, Mudan S, Pancreatic cancer in England and Wales 1975–2000: patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther 2006;23:1205–14.
   PubMed Web of Science ®Google Scholar
• Gawron AJ, Gapstur SM, Fought AJ, Talamonti MS, Skinner HG. Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol 2008;97:578–82.
   PubMedGoogle Scholar
• Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study. Am J Gastroenterol 2007;102:1377–82.
   PubMed Web of Science ®Google Scholar
• David M, Lepage C, Jouve JL, Jooste V, Chauvenet M, Faivre J, Management and prognosis of pancreatic cancer over a 30-year period. Br J Cancer. 2009;101:215–8.
   PubMed Web of Science ®Google Scholar
• Hartwig W, Schneider L, Diener MK, Bergmann F, Buchler MW, Werner J. Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg 2009;96:5–20.
   PubMedGoogle Scholar
• Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005;54:385–7.
   PubMed Web of Science ®Google Scholar
• Cancer Registry of Norway. Available at: www.kreftregisteret.no.
   Google Scholar
• Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009 May;45(7):1218–31.
   Google Scholar
• Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005;114:992–5.
   PubMed Web of Science ®Google Scholar
• Batty GD, Kivimaki M, Morrison D, Huxley R, Smith GD, Clarke R, Risk factors for pancreatic cancer mortality: Extended Follow-up of the original Whitehall study. Cancer Epidemiol Biomarkers Prev 2009 Feb;18(2):673–5.
   Google Scholar
• Teich N. Pancreatic cancer: cause and result of diabetes mellitus. Gastroenterology 2008;134:344–5.
   PubMedGoogle Scholar
• Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:197–209.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Hakansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006;98:407–13.
   PubMedGoogle Scholar
• Teras LR, Patel AV, Rodriguez C, Thun MJ, Calle EE. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States). Cancer Causes Control 2005;16:1035–40.
   PubMedGoogle Scholar
• Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005;97:1458–65.
   PubMed Web of Science ®Google Scholar
• Ghadirian P, Lynch HT, Krewski D. Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 2003;27:87–93.
   PubMedGoogle Scholar
• Qiu D, Kurosawa M, Lin Y, Inaba Y, Matsuba T, Kikuchi S, 2005;Overview of the epidemiology of pancreatic cancer focusing on the JACC Study.J Epidemiol 15Suppl 2S157–67.
   Google Scholar
• Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 1998;7:67–91.
   PubMedGoogle Scholar
• Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998;90:1710–9.
   PubMed Web of Science ®Google Scholar
• Michaud DS, Liu S, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002;94:1293–300.
   PubMed Web of Science ®Google Scholar
• Villeneuve PJ, Johnson KC, Hanley AJ, Mao Y. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 2000;9:49–58.
   PubMedGoogle Scholar
• Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88–95.
   PubMed Web of Science ®Google Scholar
• Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 2008;6:275–82.
   PubMed Web of Science ®Google Scholar
• Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006;15:704–10.
   PubMed Web of Science ®Google Scholar
• Larghi A, Verna EC, Lecca PG, Costamagna G: Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound. Clin Cancer Res 2009;15:1907–14.
   PubMed Web of Science ®Google Scholar
• Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 2002;14:1343–53.
   PubMedGoogle Scholar
• Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;128:1626–41.
   PubMed Web of Science ®Google Scholar
• Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008;247:456–62.
   PubMed Web of Science ®Google Scholar
• Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006 Nov;10(9):1199–210; discussion 1210–1.
   PubMedGoogle Scholar
• Rupp CC, Linehan DC. Extended lymphadenectomy in the surgery of pancreatic adenocarcinoma and its relation to quality improvement issues. J Surg Oncol 2009;99:207–14.
   PubMedGoogle Scholar
• Weitz J, Kienle P, Schmidt J, Friess H, Buchler MW. Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 2007;204:712–6.
   PubMedGoogle Scholar
• Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 2003;138:1316–22.
   PubMedGoogle Scholar
• Hristov B, Reddy S, Lin MDS, Cameron JL, Pawlik TM, Hruban RH, Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 2009 Apr 24. [Epub ahead of print], in press.
   Google Scholar
• Michalski CW, Erkan M, Huser N, Muller MW, Hartel M, Friess H, Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg 2008;25:473–80.
   PubMedGoogle Scholar
• Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225(5):621–33; discussion 633–6.
   PubMedGoogle Scholar
• Søreide K, Immervoll H, Molven A. Precursors to pancreatic cancer. Tidsskr Nor Laegeforen 2006;126:905–8.
   PubMedGoogle Scholar
• Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977–87.
   PubMed Web of Science ®Google Scholar